Category Archives: HIV-associated neurocognitive disorders

Study shows how neural networks adapt to the presence of a toxic HIV protein.


The incidence of HIV-associated dementia has declined dramatically since the introduction of potent combined antiretroviral therapy; however, milder forms of HIV-associated neurocognitive disorders (HAND) persist. Some 30 to 50 % of HIV-infected individuals have HAND.  With an increasing proportion of HIV-infected individuals at risk of HAND, the development of a treatment and mapping of pathology is critical.  Now, a study from

Read more